Omega Therapeutics Inc.
0.62
0.02 (3.85%)
At close: Jan 15, 2025, 12:24 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19
PE Ratio -1.67 -2.66 -7.83 -25.34 -41.31
PS Ratio 52.54 131.89 3.76K n/a n/a
PB Ratio 2.80 2.58 2.70 -11.84 -21.31
P/FCF Ratio -1.72 -2.74 -9.17 -27.39 -46.21
P/OCF Ratio -1.78 -2.78 -9.4 -29.29 -48.82
OCF/S Ratio -29.58 -47.52 -400.06 n/a n/a
Debt / Equity Ratio 2.21 0.21 0.10 -0.18 -0.33
Quick Ratio 3.34 3.80 19.16 3.12 1.19
Current Ratio 3.35 5.68 19.13 3.12 1.19
Asset Turnover 0.02 0.01 0.00 n/a n/a
Interest Coverage n/a -462.91 -72.56 -36.87 -29.14
Return on Equity (ROE) -1.68 -0.97 -0.34 0.47 0.52
Return on Assets (ROA) -0.48 -0.7 -0.3 -1.08 -3.03
Return on Capital (ROIC) -0.56 -0.83 -0.3 -1.41 -4.45
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin -2.03K% -150.36% -863.19% n/a n/a
Net Profit Margin -3.15K% -4.95K% -48.03K% n/a n/a
Pretax Profit Margin -3.15K% -4.95K% -47.42K% n/a n/a
Operating Profit Margin -3.24K% -4.96K% -45.86K% n/a n/a
FCF Margin -3.05K% -4.82K% -41.02K% n/a n/a
EBITDA Margin -3.02K% -4.71K% -44.89K% n/a n/a